Search Results 1561-1570 of 18447 for Immunode

1. A Study Comparing The Efficacy, Safety And Tolerability Of Fixed Dose Combination (FDC) Of FF/UMEC/VI With The FDC Of FF/VI And UMEC/VI; Administered Once-daily Via A Dry Powder Inhaler (DPI) In Subjects With Chronic Obstructive Pulmonary Disease (COPD) - Mayo Clinic

   Risk Factors for Pneumonia: immune suppression (e.g. human immunodeficiency virus [HIV], Lupus) or other risk factors for pneumonia (e.g. neurological ...

2. Study Of Efficacy And Safety Of LNP023 In Primary IgA Nephropathy Patients - Mayo Clinic

   * Any secondary IgAN as defined by the investigator; secondary IgAN can be associated with cirrhosis, celiac disease, Human Immunodeficiency Virus (HIV) ...

3. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

   History or known presence of recurrent or chronic infection (e.g., hepatitis B virus [HBV], hepatitis C virus [HCV], human immunodeficiency virus [HIV]); ...

4. Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes (REVITALIZE 1) - Mayo Clinic

   ... immunodeficiency virus (HIV); are on potential immunosuppressants; or individuals whose immune status makes the subject a poor candidate for clinical trial ...

5. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

   Negative human immunodeficiency virus (HIV) antibody;; Negative hepatitis B surface antigen (HBsAg) and negative hepatitis B core (HBc) antibody or ...

6. Atazanavir and cobicistat (oral route) - Side effects & dosage - Mayo Clinic

   Atazanavir and cobicistat combination is used together with other medicines to treat human immunodeficiency virus (HIV) infection. HIV is the virus that ...

7. Publications - Paschalis Vergidis, M.D., M.S. - Mayo Clinic

   ... immunodeficiency virus infection. Infect Dis Clin North Am. 2009 Jun; 23 (2):295-308. View PubMed; Vergidis PI, Falagas ME. New antibiotic agents for ...

8. Pirtobrutinib And Venetoclax With MRD Detection For Previously Untreated Chronic Lymphocytic Leukemia - Mayo Clinic

   * Patients who have tested positive for Human Immunodeficiency Virus (HIV) are excluded due to potential drug-drug interactions between anti-retroviral ...

9. Cabotegravir and rilpivirine (intramuscular route) - Side effects & uses - Mayo Clinic

   Cabotegravir and rilpivirine combination injection are used together for the treatment of the human immunodeficiency virus type 1 (HIV-1) infection. HIV is ...

10. An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Soc, Versus SoC Alone, in Adult Male Patients With mHSPC - Mayo Clinic

    Human immunodeficiency virus (HIV)-infected patients who are healthy and have a low risk of acquired immune deficiency syndrome (AIDS)-related outcomes can ...